Inflammation in Waldenström macroglobulinemia is associated with 6q deletion and need for treatment initiation-Reference-Cited by-同舟云学术

Inflammation in Waldenström macroglobulinemia is associated with 6q deletion and need for treatment initiation

Published:2022-07-14 Issue:11 Volume:107 Page:2720-2724
ISSN:1592-8721
Container-title:Haematologica
language:
Short-container-title:haematol

Author:

Forgeard Nathalie,Baron Marine,Caron Jonathan,Boccon-Gibod Clementine,Krzisch Daphne,Guedes Nayara,Morel Veronique,Jacque Nathalie,Ouzegdouh Maya,Choquet Sylvain,Bravetti Clotilde,Nguyen-Khac Florence,Chapiro Elise,Leblond Veronique,Roos-Weil Damien

Publisher

Ferrata Storti Foundation (Haematologica)

Subject

Hematology

Reference16 articles.

1. Braggio E, Philipsborn C, Novak A, Hodge L, Ansell S, Fonseca R. Molecular pathogenesis of Waldenström’s macroglobulinemia. Haematologica. 2012; 97(9):1281-1290.

2. Hunter ZR, Xu L, Yang G. The genomic landscape of Waldenström macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis. Blood. 2014; 123(11):1637-1646.

3. Nguyen-Khac F, Lambert J, Chapiro E. Chromosomal aberrations and their prognostic value in a series of 174 untreated patients with Waldenström’s macroglobulinemia. Haematologica. 2013; 98(4):649-654.

4. Krzisch D, Guedes N, Boccon-Gibod C. Cytogenetic and molecular abnormalities in Waldenström’s macroglobulinemia patients: correlations and prognostic impact. Am J Hematol. 2021; 96(12):1569-1579.

5. Pophali PA, Bartley A, Kapoor P. Prevalence and survival of smouldering Waldenström macroglobulinaemia in the United States. Br J Haematol. 2019; 184(6):1014-1017.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Waldenström Macroglobulinemia in Very Elderly (≥75-year-old) Patients: A 33-year-retrospective Cohort Study in an Italian University Hospital;HemaSphere;2023-10

2. Inflammation is predictive of outcome in Waldenström macroglobulinemia treated by Bruton tyrosine kinase inhibitors: a multicentric real-life study;Haematologica;2023-08-16

3. Report of Consensus Panel 3 from the 11th International workshop on Waldenström's Macroglobulinemia: Recommendations for molecular diagnosis in Waldenström's Macroglobulinemia;Seminars in Hematology;2023-03